All new medicines in Britain must now come with a comprehensive manufacturer's leaflet inside the pack. Within two years all existing medicines will also include such a leaflet This is the most important change for over a decade in the provision of information to patients. However, the claimed benefits from these leaflets will not be available to the 1.7 million people in Britain with impaired vision. Most visually impaired people are elderly, a group that is prescribed nearly half of all prescription drugs. Most live alone and have to rely on friends, families, or neighbours to read information for them. When this is medical information, the preference for privacy and confidentiality is obvious.
展开▼
